.Pharmacolibrary.Drugs.C_CardiovascularSystem.C02D_ArteriolarSmoothMuscleAgentsActingOn.C02DB03_Endralazine.Endralazine .Pharmacolibrary.Drugs.C_CardiovascularSystem.C02D_ArteriolarSmoothMuscleAgentsActingOn.C02DB03_Endralazine.Endralazine| name: | Endralazine | |
| ATC code: | C02DB03 | route: | oral |
| compartments: | 1 | |
| dosage: | 20 | mg |
| volume of distribution: | 200 | L |
| clearance: | 60 | L/h |
| other parameters in model implementation | ||
Endralazine is a hydrazinophthalazine derivative antihypertensive drug that acts as a vasodilator, formerly used in the management of hypertension. It is not widely used today and does not appear to be marketed or approved in most countries currently.
Estimated pharmacokinetic parameters for a typical adult following oral administration, as no published clinical pharmacokinetic studies have been found for endralazine.